VIDEO: Systemic therapies may run risk of retinal toxicity

ORLANDO — In this Healio Video Perspective from Telling It Like It Is, Jaclyn L. Kovach, MD, FASRS, overviews systemic therapies and retinal toxicity.
Kovach mentioned pigmentary maculopathy with the use of pentosan polysulfate sodium and said that Ozempic (semaglutide, Novo Nordisk) may “accelerate the progression of diabetic retinopathy” in rare instances.